|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$43,373
|
N/A
|
National Institutes of Health
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$397,218
|
$397,218
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Androgen Receptor in Bladder Cancer
|
ZIA BC 011527
|
$44,135
|
$44,135
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus
|
ZIA BC 011528
|
$17,654
|
$17,654
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Contribution of Y-specific Genes to Bladder Cancer
|
ZIA BC 011591
|
$176,541
|
$176,541
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a Novel Tumor Suppressor
|
ZIA BC 011592
|
$114,752
|
$114,752
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigentic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$44,135
|
$44,135
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$88,271
|
$88,271
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$709,489
|
$70,949
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$176,965
|
$176,965
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$265,448
|
$265,448
|
Apolo, Andrea
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$456,868
|
$456,868
|
Barchi, Joseph
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$93,272
|
$23,318
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$139,909
|
$27,982
|
Bates, Susan
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$238,328
|
$71,498
|
Beutler, John
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$102,756
|
$102,756
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$77,067
|
$7,707
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$333,956
|
$116,885
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$368,848
|
$258,194
|
Buck, Christopher
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,009,947
|
$100,995
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$316,811
|
$158,405
|
Citrin, Deborah
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
$735,209
|
Custer, Mary
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$848,869
|
$169,774
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$53,961
|
$26,981
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,417,672
|
$425,301
|
Edelman, Daniel
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$389,472
|
$19,474
|
Feldman, Steven
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$551,199
|
$55,120
|
Figg, William
|
CCR (NCI)
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$389,726
|
$194,863
|
Fojo, Antonio
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$267,157
|
$53,431
|
Fowler, Daniel
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$531,398
|
$53,140
|
Garfield, Susan
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$333,231
|
$6,665
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$999,694
|
$49,985
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,436,451
|
$443,645
|
Gulley, James
|
CCR (NCI)
|
|
Computer-Aided Detection of Urinary Tract Cancer on MDCT Urography
|
5R01CA134688-05
|
$353,464
|
$176,732
|
HADJIYSKI, LUBOMIR
|
UNIVERSITY OF MICHIGAN
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$531,130
|
$53,113
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Applied Molecular Pathology Laboratory
|
ZIC BC 011257
|
$158,649
|
$6,346
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$878,463
|
$351,385
|
Hou, Steven
|
CCR (NCI)
|
|
Development and use of nanoFACS for analysis and sorting of nanoparticles
|
ZIA BC 011502
|
$294,534
|
$14,727
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$358,240
|
$7,165
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$787,265
|
$39,363
|
Khan, Javed
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,176,083
|
$58,804
|
Kleiner, David
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$7,799
|
$3,899
|
Kong, Heidi
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$238,893
|
$47,779
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$506,830
|
$380,122
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,013,660
|
$760,245
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,013,660
|
$1,003,523
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$760,245
|
$456,147
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,773,905
|
$1,419,124
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$264,572
|
$26,457
|
Mackem, Susan
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$797,143
|
$159,429
|
Meier, Jordan
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $16,026,237
|